SB 201146

a trisubstituted pyridine with high affinity for the LTB4 receptor; leukotriene B4 antagonist; structure in first source

Also Known As:

3-(6-(((3-aminophenyl)sulfinyl)methyl)-3-((8-(4-methoxyphenyl)octyl)oxy)pyridin-2-yl)acrylic acid lithium salt; SB-201146; SB201146

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Respiratory Hypersensitivity 07/01/1999 - "Treatment with SB 210661, pranlukast or SB 201146 significantly attenuated eosinophil recruitment into the lungs, whilst having no significant effect on airway hyperresponsiveness. "